Lv2
110 积分 2022-11-30 加入
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
3个月前
已完结
PD1 agonist antibody passes first phase II trial for autoimmune disease
4个月前
已完结
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases
5个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
6个月前
已完结
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
6个月前
已完结
Chemoimmunotherapy synergism: mechanisms and clinical applications
6个月前
已完结
Decoding the molecular interplay of CD20 and therapeutic antibodies with fast volumetric nanoscopy
7个月前
已完结
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
8个月前
已完结
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
11个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1年前
已完结
皖公网安备34019202002308
